A Multi-hospital Before–After Observational Study Using a Point-Prevalence Approach with an Infusion Safety Intervention Bundle to Reduce Intravenous Medication Administration Errors

Kumiko O. Schnock (), Patricia C. Dykes, Jennifer Albert, Deborah Ariosto, Caitlin Cameron, Diane L. Carroll, Moreen Donahue, Adrienne G. Drucker, Rosemary Duncan, Linda Fang, Marla Husch, Nicole McDonald, Ray R. Maddox, Julie McGuire, Sally Rafie, Emilee Robertson, Melinda Sawyer, Elizabeth Wade, Catherine S. Yoon, Stuart Lipsitz and David W. Bates
Additional contact information
Kumiko O. Schnock: Brigham and Women’s Hospital
Patricia C. Dykes: Brigham and Women’s Hospital
Jennifer Albert: Massachusetts General Hospital
Deborah Ariosto: Vanderbilt University Medical Center
Caitlin Cameron: University of Arizona
Diane L. Carroll: Massachusetts General Hospital
Moreen Donahue: Western Connecticut Health Network
Adrienne G. Drucker: Partners eCare, Partners Healthcare
Rosemary Duncan: The Johns Hopkins Hospital
Linda Fang: Winchester Medical Center
Marla Husch: Health Quest Systems Inc
Nicole McDonald: Maricopa Medical Center
Ray R. Maddox: University of Georgia
Julie McGuire: Central DuPage Hospital
Sally Rafie: UC San Diego Health
Emilee Robertson: St. Joseph’s/Candler Health System
Melinda Sawyer: The Johns Hopkins Hospital
Elizabeth Wade: Concord Hospital
Catherine S. Yoon: Brigham and Women’s Hospital
Stuart Lipsitz: Brigham and Women’s Hospital
David W. Bates: Brigham and Women’s Hospital

Drug Safety, 2018, vol. 41, issue 6, No 5, 602 pages

Abstract: Abstract Introduction We previously found a high rate of errors in the administration of intravenous medications using smart infusion pumps. Objectives/Design An infusion safety intervention bundle was developed in response to the high rate of identified errors. A before–after observational study with a prospective point-prevalence approach was conducted in nine hospitals to measure the preliminary effects of the intervention. Main Outcome Measures Primary outcome measures were overall errors and medication errors, with the secondary outcome defined as potentially harmful error rates. Results We assessed a total of 418 patients with 972 medication administrations in the pre-intervention period and 422 patients with 1059 medication administrations in the post-intervention period. The overall error rate fell from 146 to 123 per 100 medication administrations (p

Date: 2018
References: View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://link.springer.com/10.1007/s40264-018-0637-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0637-3

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-018-0637-3

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().